YK

Yogita Kalwani

Active Director Director DIN 08684056
DIN 08684056 First appointment Jan 2020 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Yogita Kalwani

Data last updated:

Yogita Kalwani is a Director at Reviresco Pharmaceuticals Private Limited (since 2020). The company operates in Business Services.

DIN 08684056
Primary Designation Director
Industry Business Services
First Appointment 30 Jan 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jan 20202020Active

Board colleagues of Yogita Kalwani

NameDINCompanyDesignation
Manish Kumar Jain08684055Reviresco Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Reviresco Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Yogita Kalwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogita Kalwani

Yogita Kalwani currently holds 1 directorship: Reviresco Pharmaceuticals Private Limited (Director, since 30 Jan 2020).

Yogita Kalwani was first appointed on 30 Jan 2020 as Director at Reviresco Pharmaceuticals Private Limited.

The current boards of Yogita Kalwani's companies include Manish Kumar Jain (Reviresco Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available